Concepedia
Statistics
Publications
16
Citations
1.4K
H-Index
14
Active since
2004
Affiliations
Eli Lilly (United States)(Current)
Pfizer (United States)
Novartis (United States)
Merck & Co., Inc., Rahway, NJ, USA (United States)
Berry & Associates (United States)
Brenda Gaydos is an author at Eli Lilly (United States) specializing in medicine, drug discovery, and pharmacology.
Top concepts
MedicinePharmacologyDrug DiscoveryDesignHealthClinical Trial DesignHealth PolicyClinical TrialsPharmacotherapyClinical Trial Management
Publications per year
2004–2014
Practice effects and the use of alternate forms in serial neuropsychological testing
Leigh J. Beglinger, Brenda Gaydos, Kevin Duff et al. · Archives of Clinical Neuropsychology · 2005 · 358 citations · Full text
Neuropsychology, Psychopharmacology, Cognitive Rehabilitation +19
Adaptive Designs in Clinical Drug Development—An Executive Summary of the PhRMA Working Group
Paul Gallo, Christy Chuang‐Stein, Vladimir Dragalin et al. · Journal of Biopharmaceutical Statistics · 2006 · 305 citations
White Paper, Optimal Experimental Design, Pharmacotherapy +18
Innovative Approaches for Designing and Analyzing Adaptive Dose-Ranging Trials
Björn Bornkamp, Frank Bretz, Alex Dmitrienko et al. · Journal of Biopharmaceutical Statistics · 2007 · 193 citations
Pharmacotherapy, Inadequate Selection, Adaptive Dose-ranging Methods +17
Good Practices for Adaptive Clinical Trials in Pharmaceutical Product Development
Brenda Gaydos, Keaven M. Anderson, Donald A. Berry et al. · Drug Information Journal · 2009 · 115 citations
Adaptive Clinical Trials, Clinical Trial Management, Pharmacology +10
Dose‐finding results in an adaptive, seamless, randomized trial of once‐weekly dulaglutide combined with metformin in type 2 diabetes patients (<scp>AWARD</scp>‐5)
Zachary Skrivanek, Brenda Gaydos, Jenny Y. Chien et al. · Diabetes Obesity and Metabolism · 2014 · 62 citations · Full text
1–5 of 16